FDA Approval of Daraxonrasib Marks Turning Point in Pancreatic Cancer Care
Sylvester Comprehensive Cancer Center researchers report an FDA approval for a pancreatic cancer pill that nearly doubled survival, alongside new ...
Sylvester Comprehensive Cancer Center researchers report an FDA approval for a pancreatic cancer pill that nearly doubled survival, alongside new ...
A new review in Aging Cell positions endothelial TLR4 as a context-dependent molecular rheostat controlling vascular senescence, arguing that precision ...
UCLA oncologist Dr. Dennis Slamon has received the 2026 Albany Prize for discoveries that identified HER2-positive breast cancer and produced ...
A Dutch registry study finds the number of patients living long-term with de novo metastatic incurable cancer more than quadrupled ...
A new study finds the experimental cancer drug zavondemstat and the research compound QC6352 act mainly by blocking the enzyme ...
A multicenter real-world study of 465 patients found that adding brain radiotherapy to first-line third-generation EGFR inhibitors improved survival in ...
New research shows that CBP-driven histone H3K18 lactylation activates GLI2 transcription, promoting head and neck squamous cell carcinoma progression and ...
A new review in the Journal of Translational Medicine argues that c-MET signaling shapes spatially confined, metabolically driven immunosuppressive niches ...
A new review in Annals of Hematology details how molecular profiling and a growing arsenal of targeted and immune-based therapies ...
A new review in the Journal of Translational Medicine shows how combining molecular imaging, genomic profiling, and computational biology is ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine